Polycystic Ovaries: A Cross-Sectional Study on Unmarried Girls in Saudi Arabia

    January 2023 in “ Austin Journal of Obstetrics and Gynecology ”
    Maha Al Qallaf
    TLDR PCOS affects many young women in KSA, with mild cases being most common.
    A cross-sectional study conducted on 778 unmarried girls and adolescents aged 15–24 years in KSA aimed to determine the prevalence of Polycystic Ovary Syndrome (PCOS). Out of 600 participants who completed all tests, the study found a PCOS prevalence of 22.5% according to the Rotterdam criteria and 10.7% according to the Androgen Excess Association criteria. The most common phenotype observed was mild PCOS, characterized by oligomenorrhea and polycystic ovaries on ultrasound, affecting 52.6% of the cases. Additionally, 71.8% of PCOS cases identified by the Rotterdam criteria were not associated with H. pylori infection. The study highlights the need for community-based prevalence data on PCOS in KSA.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 6 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    4 / 4 results